Experts Suggest Targeting How To Treat Migraine.
The holidays can call into doubt the estimated 30 million migraine sufferers in the United States as they look over to deal with crowds, fraternize delays, stress and other potential headache triggers. Even if you don't get the debilitating headaches, there's a high-mindedness chance you have loved ones who do. Nearly one in four US households includes someone afflicted with migraines, according to the Migraine Research Foundation. There are a sum of ways to make do with migraines during the holidays, said David Yeomans, director of pain research at the Stanford University School of Medicine Dec 2013.
Along with expert and trying to avoid your migraine triggers, you deprivation to be prepared to deal with a headache. Light sensitivity, changes in sleep patterns, and certain foods and smells - all base migraine triggers - might be harder to avoid during the holiday season. "When you've got kinsmen over or are at a loved one's home, it can be tricky to adjust your normal pattern or routine," Yeomans said in a news release.
Showing posts with label migraine. Show all posts
Showing posts with label migraine. Show all posts
Wednesday, 20 November 2019
Friday, 2 March 2018
New Treatment For Migraine
New Treatment For Migraine.
The US Food and Drug Administration has approved the commencement thingamajig aimed at easing the pain of migraines preceded by aura - sensory disturbances that come about just before an attack. About a third of migraine sufferers experience auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a asseveration released Friday Dec, 2013. Patients use both hands to hold the mark of cadency against the back of their head and press a button so that the coat of arms can release a pulse of magnetic energy. This pulse stimulates the brain's occipital cortex, which may stem or ease migraine pain.
And "Millions of people suffer from migraines, and this rejuvenated device represents a new treatment option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement. The agency's concurrence is based on a adversity involving 201 patients who had suffered moderate-to-strong migraine with aura.
The US Food and Drug Administration has approved the commencement thingamajig aimed at easing the pain of migraines preceded by aura - sensory disturbances that come about just before an attack. About a third of migraine sufferers experience auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a asseveration released Friday Dec, 2013. Patients use both hands to hold the mark of cadency against the back of their head and press a button so that the coat of arms can release a pulse of magnetic energy. This pulse stimulates the brain's occipital cortex, which may stem or ease migraine pain.
And "Millions of people suffer from migraines, and this rejuvenated device represents a new treatment option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement. The agency's concurrence is based on a adversity involving 201 patients who had suffered moderate-to-strong migraine with aura.
Thursday, 28 December 2017
Implantable Devices Are Not A Panacea, But The Ability To Relieve Migraine Attacks
Implantable Devices Are Not A Panacea, But The Ability To Relieve Migraine Attacks.
An implantable plot covert in the nape of the neck may excellent more headache-free days for people with severe migraines that don't respond to other treatments, a unknown study suggests. More than 36 million Americans get migraine headaches, which are marked by perfervid pain, sensitivity to light and sound, nausea and vomiting, according to the Migraine Research Foundation. Medication and lifestyle changes are the first-line treatments for migraine, but not one and all improves with these measures.
The St Jude Medical Genesis neurostimulator is a short, all skin and bones strip that is implanted behind the neck. A battery bunch is then implanted elsewhere in the body. Activating the device stimulates the occipital nerve and can crepuscular the pain of migraine headache. "There are a large number of patients for whom nothing works and whose lives are ruined by the circadian pain of their migraine headache, and this device has the potential to help some of them," said scan author Dr Stephen D Silberstein, director of the Jefferson Headache Center in Philadelphia.
The study, which was funded by monogram manufacturer St Jude Medical Inc, is slated for debut on Thursday at the International Headache Congress in Berlin, and is the largest study to date on the device. The partnership is now seeking approval for the device in Europe and then plans to submit their data to the US Food and Drug Administration for sanction in the United States.
Researchers tested the new device in 157 populace who had severe migraines about 26 days out of each month. After 12 weeks, those who received the restored device had seven more headache-free days per month, compared to one more headache-free day per month seen amongst people in the control group.
Individuals in the control arm did not receive stimulation until after the anything else 12 weeks. Study participants who received the stimulator also reported less severe headaches and improvements in their dignity of life. After one year, 66 percent of people in the study said they had ripping or good pain relief.
The pain reduction seen in the study did fall short of FDA standards, which whoop for a 50 percent reduction in pain. "The device is invisible to the eye, but not to the touch". The implantation course of action involves local anesthesia along with conscious sedation so you are awake, but not fully aware.
There may be some forbearing pain associated with this surgery. Study co-author Dr Joel Saper, collapse and director of Michigan Head Pain and Neurological Institute in Ann Arbor, and a associate of the advisory board for the Migraine Research Foundation, said this therapy could be an important option for some bodies with migraines.
An implantable plot covert in the nape of the neck may excellent more headache-free days for people with severe migraines that don't respond to other treatments, a unknown study suggests. More than 36 million Americans get migraine headaches, which are marked by perfervid pain, sensitivity to light and sound, nausea and vomiting, according to the Migraine Research Foundation. Medication and lifestyle changes are the first-line treatments for migraine, but not one and all improves with these measures.
The St Jude Medical Genesis neurostimulator is a short, all skin and bones strip that is implanted behind the neck. A battery bunch is then implanted elsewhere in the body. Activating the device stimulates the occipital nerve and can crepuscular the pain of migraine headache. "There are a large number of patients for whom nothing works and whose lives are ruined by the circadian pain of their migraine headache, and this device has the potential to help some of them," said scan author Dr Stephen D Silberstein, director of the Jefferson Headache Center in Philadelphia.
The study, which was funded by monogram manufacturer St Jude Medical Inc, is slated for debut on Thursday at the International Headache Congress in Berlin, and is the largest study to date on the device. The partnership is now seeking approval for the device in Europe and then plans to submit their data to the US Food and Drug Administration for sanction in the United States.
Researchers tested the new device in 157 populace who had severe migraines about 26 days out of each month. After 12 weeks, those who received the restored device had seven more headache-free days per month, compared to one more headache-free day per month seen amongst people in the control group.
Individuals in the control arm did not receive stimulation until after the anything else 12 weeks. Study participants who received the stimulator also reported less severe headaches and improvements in their dignity of life. After one year, 66 percent of people in the study said they had ripping or good pain relief.
The pain reduction seen in the study did fall short of FDA standards, which whoop for a 50 percent reduction in pain. "The device is invisible to the eye, but not to the touch". The implantation course of action involves local anesthesia along with conscious sedation so you are awake, but not fully aware.
There may be some forbearing pain associated with this surgery. Study co-author Dr Joel Saper, collapse and director of Michigan Head Pain and Neurological Institute in Ann Arbor, and a associate of the advisory board for the Migraine Research Foundation, said this therapy could be an important option for some bodies with migraines.
Friday, 5 December 2014
Migraine May Increase The Risk Of Heart Attacks And Strokes
Migraine May Increase The Risk Of Heart Attacks And Strokes.
Women who let from migraines with visual crap called aura may face an increased imperil for heart attacks, strokes and blood clots, new studies find. Only enormous blood pressure was a more powerful predictor of cardiovascular trouble, the researchers said. There are things women with this genus of migraine can do to reduce that risk, they added: lower blood strength and cholesterol levels, avoid smoking, eat healthfully and exercise. "Other studies have found that this type of migraine has been associated with the risk of stroke, and may be associated with any cardiovascular disease," said lead designer Dr Tobias Kurth, from the French National Institute of Health and Medical Research in Bordeaux and Brigham and Women's Hospital in Boston.
So "We on migraine with aura is a quite conclusive contributor to major cardiovascular disease. It is one of the top two risk factors". Other studies have found the jeopardy for cardiovascular disease for people who suffer from migraines with aura is roughly two-ply that of people without the condition, Kurth noted. People who suffer from migraines with aura see flickering lights or other visual clobber just before the headache kicks in, he explained.
The findings are to be presented in March at the American Academy of Neurology annual meet in San Diego. For the study, Kurth's crew collected data on nearly 28000 women who took part in the Women's Health Study. Among these women, more than 1400 suffered from migraines with aura.
During 15 years of follow-up, more than 1000 women had a focus attack, accomplishment or died from cardiovascular causes, the researchers found. After height blood pressure, migraine with aura was the strongest predictor for having a heart spasm or stroke among these women. The risk was even more pronounced than that associated with diabetes, smoking, plumpness and a family history of heart disease, the investigators noted.
Whether controlling migraines reduces the hazard for heart disease isn't known, Kurth said. The study found a link between migraines with character and cardiovascular trouble, but it didn't prove cause-and-effect. Although women who have migraine with atmosphere seem to have this increased risk, it doesn't doom everyone who has migraines with aura to have a heart attack or stroke, Kurth noted.
Women who let from migraines with visual crap called aura may face an increased imperil for heart attacks, strokes and blood clots, new studies find. Only enormous blood pressure was a more powerful predictor of cardiovascular trouble, the researchers said. There are things women with this genus of migraine can do to reduce that risk, they added: lower blood strength and cholesterol levels, avoid smoking, eat healthfully and exercise. "Other studies have found that this type of migraine has been associated with the risk of stroke, and may be associated with any cardiovascular disease," said lead designer Dr Tobias Kurth, from the French National Institute of Health and Medical Research in Bordeaux and Brigham and Women's Hospital in Boston.
So "We on migraine with aura is a quite conclusive contributor to major cardiovascular disease. It is one of the top two risk factors". Other studies have found the jeopardy for cardiovascular disease for people who suffer from migraines with aura is roughly two-ply that of people without the condition, Kurth noted. People who suffer from migraines with aura see flickering lights or other visual clobber just before the headache kicks in, he explained.
The findings are to be presented in March at the American Academy of Neurology annual meet in San Diego. For the study, Kurth's crew collected data on nearly 28000 women who took part in the Women's Health Study. Among these women, more than 1400 suffered from migraines with aura.
During 15 years of follow-up, more than 1000 women had a focus attack, accomplishment or died from cardiovascular causes, the researchers found. After height blood pressure, migraine with aura was the strongest predictor for having a heart spasm or stroke among these women. The risk was even more pronounced than that associated with diabetes, smoking, plumpness and a family history of heart disease, the investigators noted.
Whether controlling migraines reduces the hazard for heart disease isn't known, Kurth said. The study found a link between migraines with character and cardiovascular trouble, but it didn't prove cause-and-effect. Although women who have migraine with atmosphere seem to have this increased risk, it doesn't doom everyone who has migraines with aura to have a heart attack or stroke, Kurth noted.
Subscribe to:
Posts (Atom)